CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIV. COMPARATIVE STUDIES ON THE NUTRITIVE VALUE OF ORALLY AND INTRAVENOUSLY ADMINISTERED HUMAN SERUM ALBUMIN IN MAN

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston}

^{Department of Medicine, Harvard Medical School, Boston}

This is paper No. 57 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Mass., on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

This study was aided in part by a grant from the Abbott Laboratories, North Chicago, Ill.

The albumin administered intravenously was obtained in part from the Bureau of Medicine and Surgery, U. S. Navy Department, and in part was specially prepared by the Plasma Fractionation Laboratory, Harvard Medical School, under a contract recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. The albumin administered orally was supplied by the Medical Research Division, Sharp and Dohme, Inc., Glenholden, Pa.

Find articles by Eckhardt, R. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston}

^{Department of Medicine, Harvard Medical School, Boston}

This is paper No. 57 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Mass., on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

This study was aided in part by a grant from the Abbott Laboratories, North Chicago, Ill.

The albumin administered intravenously was obtained in part from the Bureau of Medicine and Surgery, U. S. Navy Department, and in part was specially prepared by the Plasma Fractionation Laboratory, Harvard Medical School, under a contract recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. The albumin administered orally was supplied by the Medical Research Division, Sharp and Dohme, Inc., Glenholden, Pa.

Find articles by Lewis, J. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston}

^{Department of Medicine, Harvard Medical School, Boston}

This is paper No. 57 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Mass., on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

This study was aided in part by a grant from the Abbott Laboratories, North Chicago, Ill.

The albumin administered intravenously was obtained in part from the Bureau of Medicine and Surgery, U. S. Navy Department, and in part was specially prepared by the Plasma Fractionation Laboratory, Harvard Medical School, under a contract recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. The albumin administered orally was supplied by the Medical Research Division, Sharp and Dohme, Inc., Glenholden, Pa.

Find articles by Murphy, T. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston}

^{Department of Medicine, Harvard Medical School, Boston}

This is paper No. 57 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Mass., on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

This study was aided in part by a grant from the Abbott Laboratories, North Chicago, Ill.

The albumin administered intravenously was obtained in part from the Bureau of Medicine and Surgery, U. S. Navy Department, and in part was specially prepared by the Plasma Fractionation Laboratory, Harvard Medical School, under a contract recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. The albumin administered orally was supplied by the Medical Research Division, Sharp and Dohme, Inc., Glenholden, Pa.

Find articles by Batchelor, W. in: PubMed | Google Scholar

^{Thorndike Memorial Laboratory, Second and Fourth Medical Services [Harvard], Boston City Hospital, Boston}

^{Department of Medicine, Harvard Medical School, Boston}

This is paper No. 57 in the series, “Studies on Plasma Proteins,” from the Harvard Medical School, Boston, Mass., on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

This study was aided in part by a grant from the Abbott Laboratories, North Chicago, Ill.

The albumin administered intravenously was obtained in part from the Bureau of Medicine and Surgery, U. S. Navy Department, and in part was specially prepared by the Plasma Fractionation Laboratory, Harvard Medical School, under a contract recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. The albumin administered orally was supplied by the Medical Research Division, Sharp and Dohme, Inc., Glenholden, Pa.

Find articles by Davidson, C. in: PubMed | Google Scholar